Singapore markets close in 6 hours 24 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
13.340.00 (0.00%)
At close: 04:00PM EDT
13.35 +0.01 (+0.07%)
After hours: 06:40PM EDT
Show:
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
4,263,762,000
-
4,027,478,000
3,569,006,000
3,197,812,000
3,291,188,000
Cost of revenue
1,426,678,000
-
1,244,072,000
1,106,846,000
994,308,000
1,089,764,000
Gross profit
2,837,084,000
-
2,783,406,000
2,462,160,000
2,203,504,000
2,201,424,000
Operating expenses
Research development
729,924,000
-
633,325,000
526,087,000
455,833,000
492,381,000
Selling general and administrative
1,053,819,000
-
997,309,000
886,361,000
875,663,000
964,737,000
Total operating expenses
2,623,008,000
-
2,230,300,000
1,928,585,000
1,805,437,000
1,945,099,000
Operating income or loss
214,076,000
-
553,106,000
533,575,000
398,067,000
256,325,000
Interest expense
219,850,000
-
116,973,000
122,432,000
130,806,000
149,010,000
Total other income/expenses net
6,473,000
-
-42,374,000
-103,831,000
106,321,000
-170,430,000
Income before tax
52,791,000
-
375,090,000
302,571,000
366,235,000
-60,754,000
Income tax expense
-91,406,000
-
58,052,000
72,405,000
-9,936,000
-105,044,000
Income from continuing operations
144,197,000
-
317,038,000
230,166,000
376,171,000
44,290,000
Net income
144,067,000
-
317,017,000
230,059,000
376,005,000
44,241,000
Net income available to common shareholders
144,067,000
-
317,017,000
230,059,000
376,005,000
44,241,000
Basic EPS
61.59
46.05
102.14
73.57
120.36
-
Diluted EPS
60.67
45.58
100.97
72.94
119.48
-
Basic average shares
3,114,752
3,128,900
3,103,618
3,127,002
3,124,012
-
Diluted average shares
3,152,861
3,160,686
3,139,744
3,154,338
3,147,074
-